[
    [
        {
            "time": "",
            "original_text": "主要供应商高管任独董，亚虹医药未认定为关联方",
            "features": {
                "keywords": [
                    "供应商",
                    "高管",
                    "独董",
                    "亚虹医药",
                    "关联方"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "主要供应商高管任独董，亚虹医药未认定为关联方",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "中药龙头比茅台多涨16倍！看A股优质稀缺龙头30强",
            "features": {
                "keywords": [
                    "中药",
                    "龙头",
                    "茅台",
                    "A股",
                    "稀缺"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中药龙头比茅台多涨16倍！看A股优质稀缺龙头30强",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "300多家机构刚调研完，这只千亿市值龙头股就创历史高！",
            "features": {
                "keywords": [
                    "机构",
                    "调研",
                    "龙头股",
                    "千亿市值",
                    "历史新高"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "300多家机构刚调研完，这只千亿市值龙头股就创历史高！",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "《2020年度药品审评报告》解读：药品审评审批“速”“质”提升，全面利好医药行业发展",
            "features": {
                "keywords": [
                    "药品审评",
                    "审批",
                    "速度",
                    "质量",
                    "医药行业"
                ],
                "sentiment_score": 0.95,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "《2020年度药品审评报告》解读：药品审评审批“速”“质”提升，全面利好医药行业发展",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "基因治疗及核酸药物企业安龙生物完成数亿元A轮融资，中信医疗基金领投",
            "features": {
                "keywords": [
                    "基因治疗",
                    "核酸药物",
                    "安龙生物",
                    "融资",
                    "中信医疗基金"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "基因治疗及核酸药物企业安龙生物完成数亿元A轮融资，中信医疗基金领投",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]